• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Yearly Archive: 2005

  • Rituximab Maintenance after Chemotherapy Gives Better Outcomes in Advanced Follicular Lymphoma
    • in ASH 2005
    • — 21 Dec, 2005

    Rituximab Maintenance after Chemotherapy Gives Better Outcomes in Advanced Follicular Lymphoma

    Sandra Horning
    Sandra Horning

    Abstract 349
    Sandra Horning, Stanford University Medical Center
    It is not necessary to use rituximab along with standard CVP (cyclophosphamide, vincristine, predinsone) induction therapy in patients with advanced follicular lymphoma. However, the use of rituximab maintenance, after induction …

    Read more
    Targeted Therapies in Multiple Myeloma Treatment Decisions
    • in ASH 2005
    • — 21 Dec, 2005

    Targeted Therapies in Multiple Myeloma Treatment Decisions

    Vincent Rajkumar
    Vincent Rajkumar

    Vincent Rajkumar, Divison of Hematology, Mayo Clinic
    At a section of the hematology meeting talking about newly diagnosed multiple myeloma and the evolving treatments, Vincent Rajkumar discussed new agents such as lenolidamide and thalidomide. Audio Medica asked him …

    Read more
  • Pro-Apoptosis, mTOR Pathways: New Targets for Lymphoma
    • in ASH 2005
    • — 21 Dec, 2005

    Pro-Apoptosis, mTOR Pathways: New Targets for Lymphoma

    Owen O'Connor
    Owen O’Connor

    Owen O’Connor, Memorial Sloan-Kettering Cancer Center, New York
    Owen O’Connor also gave data from early, two studies: one looking at treating lymphoma with the drug SAHA which targets BCL-6 in the tumor preventing it’s anti-apoptotic influence; the other …

    Read more
    Non-Anthracyline Regimen May Be O.K. for Patients with Early Breast Cancer taking Trastuzumab (Herceptin)
    • in San Antonio BC 2005
    • — 11 Dec, 2005

    Non-Anthracyline Regimen May Be O.K. for Patients with Early Breast Cancer taking Trastuzumab (Herceptin)

    Dennis Slamon, UCLA School of Medicine, Los Angeles
    It may be reasonable to replace the anthracycline component of adjuvant chemotherapy with carboplatin in HER-2 positive patients with early breast cancer – provided agents such as docetaxel and trastuzumab are also …

    Read more
  • Audio Journal of Oncology – Prostate Cancer Special Edition 2005
    • in AJO
    • — 8 Dec, 2005

    Audio Journal of Oncology – Prostate Cancer Special Edition 2005

    Audio Journal of Oncology - Prostate Cancer Special Edition 2005

    Reporting from:
    – 2005 Multidisciplinary Prostate Cancer Symposium, February 17-19, Hyatt Grand Cypress, Orlando, Florida

    In this edition:

    Will they or won’t they relapse? For patients with prostate cancer, their PSA velocity before radical prostatectomy best pinpoints the risk of …

    Read more
    Audio Journal of Hematologic Malignancy Special Edition 2005
    • in AJO
    • — 8 Dec, 2005

    Audio Journal of Hematologic Malignancy Special Edition 2005

    Audio Journal of Hematologic Malignancy Special Edition 2005

    Reporting from:
    – Annual Meeting of the American Society of Hematology, December 4-7, 2004, San Diego
    – Lymphoma: The Next Questions, April 8-9, 2005, Fort Lauderdale
    – Journal of Clinical Oncology

    In this edition:

    The newer the better, so they …

    Read more
  • Audio Journal of Oncology 13.8, December 2005
    • in AJO
    • — 7 Dec, 2005

    Audio Journal of Oncology 13.8, December 2005

    Audio Journal of Oncology 13.8, December 2005

    Reporting from:
    ECCO-13 The European Cancer Conference, Paris, October 30–November 3, 2005

    In this edition:

    Martine Piccart gave the Paris ECCO conference her group’s latest data from the HERA study of breast cancer, recently published in the New England Journal …

    Read more
    Primary PCI: Better in the Real World, Too
    • in AHA 2005 · Cardiovascular
    • — 17 Nov, 2005

    Primary PCI: Better in the Real World, Too

    Primary angioplasty after a myocardial infarction is also better than thrombolysis in a real world setting: though up to two hours after the infarction the two methods are equivalent, according to Swedish findings from a study of 21 000 patients. …

    Read more
  • ENDEAVOR or Cypher? Comparison of Drug Eluting Stents
    • in AHA 2005 · Cardiovascular
    • — 17 Nov, 2005

    ENDEAVOR or Cypher? Comparison of Drug Eluting Stents

    The ABT578-eluting ENDEAVOR stent has been compared head-to-head with sirolimus-eluting Cypher. Duke University’s David Kandzari told us more.
    [audio:https://www.audiomedica.com/podcasting/aha2005/David_Kandzari.mp3]

    Click here for all the interviews from AHA 2005…

    Read more
    Statins and ARBs: a Special Combination?
    • in AHA 2005 · Cardiovascular
    • — 17 Nov, 2005

    Statins and ARBs: a Special Combination?

     John McMurray
    John McMurray

    The VALIANT trial compared ACE-inhibitor, ARB and a combination of the two in high-risk post-MI patients, and found there may be an interaction between them and statins. John McMurray from the Western Infirmary in Glasgow.
    [audio:https://www.audiomedica.com/podcasting/aha2005/John_McMurray.mp3]

    Click here …

    Read more
  • Aspirin Saves Women from Cardiovascular Death
    • in AHA 2005 · Cardiovascular
    • — 17 Nov, 2005

    Aspirin Saves Women from Cardiovascular Death

     Jeffrey Berger
    Jeffrey Berger

    A study of 9 000 women with established cardiovascular disease has found that mortality is reduced by 25 per cent among those taking aspirin, and that the dose of daily aspirin does not affect this result. Jeffrey Berger…

    Read more
    50% of Women are Over-treated in Acute Coronary Syndromes
    • in AHA 2005 · Cardiovascular
    • — 17 Nov, 2005

    50% of Women are Over-treated in Acute Coronary Syndromes

    Registry analysis suggests women often receive too much treatment with glycoprotein 2B3A inhibitors. Duke University’s Karen Alexander told us more.
    [audio:https://www.audiomedica.com/podcasting/aha2005/Karen_Alexander.mp3]

    Click here for all the interviews from AHA 2005…

    Read more
  • Next Page »
  • Sign up for AudioMedica.com news

    * = required field
    Speciality




  • Home
  • 2005

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.